Forefront Analytics, LLC

SEC CIK: 0001696802
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Forefront Analytics, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 415
Value: $258.8K
% of portfolio: 0.3%
Quarters held: 20; Since Q1 2021

Holdings of REGN by Forefront Analytics, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	415	$258.8K	0.3%	−45−9.8%	Reduced	Holders
Q1 2026	460	$355.0K	0.3%	+33+7.7%	Added	Holders
Q4 2025	427	$329.4K	0.3%	+15+3.6%	Added	Holders
Q3 2025	412	$231.8K	0.2%	−78−15.9%	Reduced	Holders
Q2 2025	490	$257.1K	0.3%	+490	New	Holders
Q1 2025	0	$0	0.0%	−368−100.0%	Sold out	Holders
Q4 2024	368	$262.1K	0.1%	+71+23.9%	Added	Holders
Q3 2024	297	$312.2K	0.1%	−31−9.5%	Reduced	Holders
Q2 2024	328	$344.7K	0.2%	−16−4.7%	Reduced	Holders
Q1 2024	344	$331.1K	0.2%	+25+7.8%	Added	Holders
Q4 2023	319	$280.2K	0.1%	+26+8.9%	Added	Holders
Q3 2023	293	$241.1K	0.1%	−48−14.1%	Reduced	Holders
Q2 2023	341	$245.0K	0.1%	−16−4.5%	Reduced	Holders
Q1 2023	357	$293.3K	0.2%	+50+16.3%	Added	Holders
Q4 2022	307	$221.5K	0.1%	−8−2.5%	Reduced	Holders
Q3 2022	315	$216.0K	0.1%	+315	New	Holders
Q2 2022	0	$0	0.0%	−515−100.0%	Sold out	Holders
Q1 2022	515	$353.0K	0.1%	+123+31.4%	Added	Holders
Q4 2021	392	$249.0K	0.1%	+10+2.6%	Added	Holders
Q3 2021	382	$233.0K	0.1%	−40−9.5%	Reduced	Holders
Q2 2021	422	$235.0K	0.1%	−83−16.4%	Reduced	Holders
Q1 2021	505	$238.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.